Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Urinary System

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43871   clinical trials with a EudraCT protocol, of which   7290   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    620 result(s) found for: Urinary System. Displaying page 1 of 31.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2011-002470-23 Sponsor Protocol Number: 2011-002470-23 Start Date*: 2011-06-09
    Sponsor Name:ISTITUTO NEUROLOGICO MEDITERRANEO NEUROMED
    Full Title: Evaluation of diagnosic accuracy of 18F-choline PET/CT in examination of patients qith prostate cancer, in relation to PSA value and its derivatives.
    Medical condition: Patients with prostate cancer histologically proved
    Disease: Version SOC Term Classification Code Term Level
    14.1 10038604 - Reproductive system and breast disorders 10038604 Reproductive system and breast disorders SOC
    14.1 10022891 - Investigations 10022891 Investigations SOC
    14.1 10038359 - Renal and urinary disorders 10038359 Renal and urinary disorders SOC
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-005552-41 Sponsor Protocol Number: ALADIN Start Date*: 2006-02-20
    Sponsor Name:IST. DI RICERCHE FARMACOLOG. M. NEGRI
    Full Title: Effect of long-acting somatostatin on disease progression in nephropathy due to autosomal dominant polycystic disease a long-term three year follow-up study
    Medical condition: Autosomal Dominant Polycystic Kidney Disease ADPKD
    Disease: Version SOC Term Classification Code Term Level
    6.1 10038359 SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2009-012696-97 Sponsor Protocol Number: IGG-PNA IVU-01 Start Date*: 2009-07-02
    Sponsor Name:ISTITUTO GIANNINA GASLINI
    Full Title: Management of children following acute pyelonefritis or recurrent urinary tract infection episodes and prevention of renal scarring: a prospective randomised controlled clinical trial.
    Medical condition: URINARY TRACT INFECTION
    Disease: Version SOC Term Classification Code Term Level
    9.1 10038359 SOC
    Population Age: Newborns, Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-024023-25 Sponsor Protocol Number: Nefrovid2010 Start Date*: 2011-09-22
    Sponsor Name:Lorenzo Victor, PhD
    Full Title: An open label, parallel groups, phase III, clinical trial to assess the antiproteinuric effects of the vitamin D derivates in patients with chronic kidney disease and vitamin D insufficiency.
    Medical condition:
    Disease: Version SOC Term Classification Code Term Level
    14.0 10038359 - Renal and urinary disorders 10038359 Renal and urinary disorders SOC
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-003337-24 Sponsor Protocol Number: 180 Start Date*: 2013-06-26
    Sponsor Name:CENTRO DI RIFERIMENTO ONCOLOGICO DI BASILICATA
    Full Title: Diagnostic imaging in prostate cancer (as in tumours with accelerated menbrane turn-over)by F-18 Fluoro-metil-choline PET/CT
    Medical condition: patients with prostate cancer istologically proven
    Disease: Version SOC Term Classification Code Term Level
    14.1 10038359 - Renal and urinary disorders 10038359 Renal and urinary disorders SOC
    14.1 10022891 - Investigations 10022891 Investigations SOC
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-006557-25 Sponsor Protocol Number: RAPYD-STUDY Start Date*: 2007-12-20
    Sponsor Name:AZIENDA OSPEDALIERA OSPEDALE POLICLINICO CONSORZIALE
    Full Title: RAPAMYCIN FOR TREATMENT OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
    Medical condition: ADPKD type I
    Disease: Version SOC Term Classification Code Term Level
    9.1 10038359 Renal and urinary disorders SOC
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2021-005856-12 Sponsor Protocol Number: 20221 Start Date*: 2022-01-31
    Sponsor Name:Helsinki University Central Hospital
    Full Title: Monoclonal gammopathies of renal significance (MGRS) in Finland
    Medical condition: Rare renal diseases linked to monoclonal gammopathy
    Disease: Version SOC Term Classification Code Term Level
    20.0 10038359 - Renal and urinary disorders 10038359 Renal and urinary disorders SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-000708-14 Sponsor Protocol Number: ONC-RCC-02 Start Date*: 2012-10-05
    Sponsor Name:ISTITUTO NAZIONALE PER LA CURA TUMORI
    Full Title: A randomized, open label, multicenter phase 2 study, to evaluate the efficacy of Sorafenib in patients with advanced Renal Cell Carcinoma (RCC) after a radical resection of the metastases.
    Medical condition: Advanced metastatic resected renal cell carcinoma
    Disease: Version SOC Term Classification Code Term Level
    15.0 10038359 - Renal and urinary disorders 10038359 Renal and urinary disorders SOC
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-003885-40 Sponsor Protocol Number: ACEARB 1 Start Date*: 2005-10-18
    Sponsor Name:AZIENDA OSPEDALIERA PROVINCIALE DI LECCO
    Full Title: ACE-inhibitors and Angiotensin two receptor antagonists in IgA nephropathy with mild proteinuria
    Medical condition: The primary aim of the study consists in testing the hypothesis that blockade of the RAS may decrease the risk of developing adverse effects in patients with benign IgAN.Such blockade would first a...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10038359 Renal and urinary disorders SOC
    Population Age: Children, Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2006-004411-21 Sponsor Protocol Number: B109LB1 Start Date*: 2007-01-04
    Sponsor Name:Organisation name was not entered
    Full Title: The effect of aldosterone inhibition on proteinuria in patients with progressive renal disease.
    Medical condition: Patients with chronic nephropathy and proteinuria over 0,5 g/24 hrs are to be given an inhibitor of aldosterone. Theory tells that aldosterone plays an active role in nephropathy and if that can be...
    Disease: Version SOC Term Classification Code Term Level
    8.1 10038359 Renal and urinary disorders SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-003045-33 Sponsor Protocol Number: FENO HSR Start Date*: 2008-08-25
    Sponsor Name:OSPEDALE S. RAFFAELE
    Full Title: Fenoldopam and renal insufficiency
    Medical condition: patients undergoing heart surgery developing, in any moment during post surgery hospitalization in Intensive Care Unit, renal problems named as "R" of RIFLE score
    Disease: Version SOC Term Classification Code Term Level
    9.1 10038359 Renal and urinary disorders SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2010-020722-18 Sponsor Protocol Number: DESMOPRESINA Start Date*: 2009-04-17
    Sponsor Name:AZIENDA OSPEDALIERA OSPEDALE POLICLINICO CONSORZIALE
    Full Title: 1-DEAMINO 8-D-ARGININA VASOPRESSIN IN PERCUTANEOUS ULTRASOUND-GUIDED RENAL BIOPSY: A RANDOMIZED CONTROLLED TRIAL
    Medical condition: Patients undergoing percutaneous ultrasound-guided biopsy of native kidney and at high risk of bleeding
    Disease: Version SOC Term Classification Code Term Level
    9.1 10038359 SOC
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2010-020401-32 Sponsor Protocol Number: darbepoetina Start Date*: 2010-01-25
    Sponsor Name:AZIENDA OSPEDALIERA OSPEDALE POLICLINICO CONSORZIALE
    Full Title: IDENTIFICATION OF OXIDATIVE-STRESS AND MICROINFLAMMATION GENES MODULATED BY ERYTHROPOIETIN ADMINISTRATION IN PATIENTS WITH RENAL TRANSPLANT AND CHRONIC RENAL FAILURE. PERSPECTIVES FOR ERYTHROPOITIN...
    Medical condition: PATIENTS WITH RENAL TRANSPLANT AND CHRONIC RENAL FAILURE
    Disease: Version SOC Term Classification Code Term Level
    9.1 10038359 SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-016762-87 Sponsor Protocol Number: early transition Start Date*: 2006-03-24
    Sponsor Name:OSPEDALE MAGGIORE DI MILANO (IRCCS)
    Full Title: a randomized, open-label study to evaluate the safety and efficacy of delayed introduction of sirolimus and concomitant tacrolimus elimination in de novo renal allograft recipients
    Medical condition: no
    Disease: Version SOC Term Classification Code Term Level
    9.1 10038359 SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2004-000805-23 Sponsor Protocol Number: LEV102341 Start Date*: 2004-09-21
    Sponsor Name:GLAXO SMITHKLINE
    Full Title: A national, multicentric, randomised, controlled trial. Applications of a critical pathway using LEVOFLOXACIN for the management of patients with abnormal PSA
    Medical condition: prostatitis
    Disease: Version SOC Term Classification Code Term Level
    6.1 10038359 SOC
    Population Age: Adults Gender: Male
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-000451-34 Sponsor Protocol Number: FARM5XWMZ4 Start Date*: 2007-10-01
    Sponsor Name:AZIENDA OSPEDALIERA UNIVERSITARIA DELLA SECONDA UNIVERSITA` DEGLI STUDI DI NAPOLI
    Full Title: Therapy of hyperhomocysteinemia in hemodialysis patients:effects of acetylcysteine and folates.
    Medical condition: Hyperhomocysteinemia in hemodialysis.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10038359 SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2004-001673-25 Sponsor Protocol Number: VALSARTAN-TRAPIANTO/04 Start Date*: 2004-07-30
    Sponsor Name:OSPEDALE S. RAFFAELE
    Full Title: EFFECTS OF ANGIOTENSIN RECEPTOR ANTAGONIST ON CHRONIC NEPHROPATY IN KIDNEY TRANSPLANTED PATIENTS. A PILOT STUDY.
    Medical condition: CHRONIC NEPHROPATY REDUCTION
    Disease: Version SOC Term Classification Code Term Level
    6.1 10038359 SOC
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2006-006656-35 Sponsor Protocol Number: A3711047 Start Date*: 2007-06-12
    Sponsor Name:Pfizer Ltd
    Full Title: A Multi-center, Randomized, Parallel Group, Double-blind, Placebo Controlled Estimation Study to Assess the Efficacy and Safety of Modified Release UK-369,003 in the Treatment of Men with Storage L...
    Medical condition: Storage male lower urinary tract symptoms (LUTS) with and without erectile dysfunction (ED).
    Disease: Version SOC Term Classification Code Term Level
    9.1 10046566 Urinary tract disorder LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: FR (Completed) FI (Completed) DE (Completed) GB (Completed) GR (Completed) LV (Completed) IT (Completed) SK (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2006-004378-28 Sponsor Protocol Number: A3711044 Start Date*: 2007-06-04
    Sponsor Name:Pfizer Ltd
    Full Title: A MULTI-CENTER, RANDOMIZED, PARALLEL GROUP, DOUBLE-BLIND, PLACEBO CONTROLLED PROOF OF CONCEPT AND DOSE RANGING STUDY WITH AN ACTIVE CONTROL TO ASSESS THE EFFICACY AND SAFETY/TOLERABILITY OF UK-369,...
    Medical condition: Lower urinary tract symptoms (LUTS) in men with and without erectile dysfunction (ED).
    Disease: Version SOC Term Classification Code Term Level
    8.1 10046566 Urinary tract disorder LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: BE (Completed) FI (Completed) DK (Completed) CZ (Completed) LT (Completed) GB (Completed) GR (Completed) IT (Completed) LV (Completed)
    Trial results: View results
    EudraCT Number: 2013-003585-14 Sponsor Protocol Number: SNOXH94C301 Start Date*: 2014-01-10
    Sponsor Name:NOXXON Pharma AG
    Full Title: Safety, PK/PD and efficacy of NOX-H94 in dialysis patients with ESA-hyporesponsive anaemia: A randomized, double blind, placebo controlled parallel group study with a single blind cross-over group
    Medical condition: Erythropoiesis stimulating agents (ESA) hyporesponsive anaemia in renal dialysis patients
    Disease: Version SOC Term Classification Code Term Level
    18.0 10038359 - Renal and urinary disorders 10038359 Renal and urinary disorders SOC
    18.0 10005329 - Blood and lymphatic system disorders 10005329 Blood and lymphatic system disorders SOC
    18.0 10005329 - Blood and lymphatic system disorders 10058123 Renal anaemia LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) DE (Completed) AT (Completed) IT (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun May 05 02:54:03 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA